Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Synthons. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.